# A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

> **NCT03575962** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 14 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GSK3640254 bis-hydrochloride salt capsule
- **DRUG:** GSK3640254 Mesylate Salt Capsule

## Key facts

- **NCT ID:** NCT03575962
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-18
- **Primary completion:** 2018-08-06
- **Final completion:** 2018-08-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575962, "A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03575962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*